Entry into mitosis triggers profound changes in cell shape and cytoskeletal 30 organisation. Here, by studying microtubule remodelling in human flat mitotic cells, 31 we identify a two-step process of interphase microtubule disassembly. First, a 32 microtubule stabilizing protein, Ensconsin, is inactivated in prophase as a 33 consequence of its phosphorylation downstream of Cdk1/CyclinB. This leads to a 34 reduction in interphase microtubule stability that may help to fuel the growth of 35 centrosomally-nucleated microtubules. The peripheral interphase microtubules that 36 remain are then rapidly lost as the concentration of tubulin heterodimers falls 37 following dissolution of the nuclear compartment boundary. Finally, we show that a 38 failure to destabilize microtubules in prophase leads to the formation of microtubule 39 clumps, which interfere with spindle assembly. Overall, this analysis highlights the 40 importance of the stepwise remodelling of the microtubule cytoskeleton, and the 41 significance of permeabilization of the nuclear envelope in coordinating the changes 42 in cellular organisation and biochemistry that accompany mitotic entry. 43 44 45 48 Cells round up, chromosomes condense, and the permeability of the nuclear 49 envelope increases (a process we term NEP), leading to mixing of nucleoplasm and 50 cytoplasm. At the same time, the array of long interphase microtubules is replaced by 51 a population of short and highly dynamic centrosome-nucleated microtubules, which 52 go on to form the mitotic spindle -the structure responsible for chromosome 53 segregation.
Introduction 46
The goal of mitosis is the equal segregation of genetic material into two daughter 47 cells. To achieve this, animal cells undergo profound changes in cell organisation.
Step 1: Cdk1/CyclinB dependent removal of Ensconsin from microtubules 167 triggers non-centrosomal microtubule depolymerisation during prophase.
168
To elucidate the molecular mechanisms that govern microtubule disassembly at the 169 entry of mitosis, we focused first on events during prophase. In order to test whether 170 the loss of interphase microtubules during this period is an indirect consequence of 171 the growth of centrosomal microtubules, e.g. via competition for a common tubulin 172 heterodimer pool, we monitored the loss of interphase microtubules in cells that fail to 173 nucleate centrosomal microtubules as the result of RNAi-mediated silencing of 174 Cep192 [37, 38] (Figure 2 A) . Importantly, since Cep192 silencing did not significantly 
179
Cdk1/CyclinB complex activity rises at around the time that interphase microtubules 180 begin to depolymerize [26] . Since Cdk1/CyclinB is thought to mediate many of the 181 structural changes that accompany entry into the mitosis, including microtubule 182 cytoskeleton remodelling [28] [29] [30] [31] [32] ), in our search for regulators of this loss of 183 interphase microtubules at the entry into mitosis, we focused our attention on 184 conserved regulators of microtubules that are potential substrates of Cdk1/CyclinB.
185
This led us to explore the function of Ensconsin in this system. This choice was 186 based upon the fact that Ensconsin (also called MAP-7 and E-MAP-115) (Figure 2 D) 187 is a microtubule-associated protein that is phosphorylated in mitosis [39] . Moreover, 188 while both fly and human Ensconsin homologues function to stabilize microtubules 189 [40] [41] [42] , the hyper-phosphorylated, mitotic form of the protein is unable to bind 190 to microtubules in vitro and in HeLa cells [39] . Further, a quantitative proteomics 191 study identified Ensconsin as a protein that preferentially binds interphase 192 microtubules [43] . Although data from some cells types does not entirely fit this 
229
of which were present in the microtubule-binding domain of Ensconsin, which we 230 showed mimics the behaviour of the full-length protein. Importantly, all have been 231 previously identified as sites of phosphorylation in mitotic cells using mass 232 spectrometry [47, 48] (just one of these sites was found to be phosphorylated in both 233 mitosis and G1 [47] ). In addition, we identified four potential Nek2 sites in the region.
234
To determine their function, we mutated these ten putative mitotic kinase sites in the 235 context of EMTB-mCherry to generate non-phosphorylatable (here called A-EMTB-236 mCherry) and phospho-mimetic variants (here called, E-EMTB-mCherry). Constructs 237 encoding wildtype, A-mutant and E-mutant versions of EMTB-mCherry were 238 transiently expressed in HeLa cells. Cells were then fixed and labelled with anti-a-239 tubulin, anti-mCherry antibodies. Whereas both the wildtype and the A-EMTB- Next to test whether this phospho-regulation has an impact on interphase 249 microtubule disassembly we transfected a HeLa GFP-a-tubulin stable cell line 250 expressing Rap1* with either a wildtype or an A-mutant version of the EMTB-251 mCherry construct. We then monitored the remodelling of the microtubule 252 cytoskeletal as cells entered mitosis live. Strikingly, the continued association of 253 mutant A-EMTB-mCherry protein with interphase microtubules was sufficient to 254 increase their stability; so that many now persisted into prometaphase (Figure 2 H) .
255
Thus, the phosphorylation of Ensconsin within the microtubule binding domain is 256 important for the timely disassembly of interphase microtubules during entry into 257 mitosis.
259
The function of interphase microtubule disassembly prior to loss of the 260 nuclear/cytoplasmic compartment boundary.
261
In many of the cells expressing A-EMTB-mCherry, the interphase microtubules that 262 fail to become destabilized upon entry into mitosis formed clumps in prometaphase, 263 which persisted on into metaphase. These microtubule clusters either became 264 incorporated into the developing spindle or were maintained intact outside the spindle 265 until the end of division (Figure 2 H, Movie S1). Interestingly, similar microtubule 266 clumps have been previously described in mitotic cells treated with the microtubule 267 stabilizing drug, Taxol [49] [50] [51] . To confirm these findings and to test whether 268 microtubule clumps seen under these conditions have a similar aetiology to those 269 seen in cells expressing A-EMTB-mCherry, we treated cells with 2nM Taxol, a dose 270 previously shown to stabilize microtubules [52] . This was sufficient to prevent the tubulin polymer assembly. This is due to the fact that the concentration of tubulin 304 11 heterodimer is a key factor in determining the dynamic behaviour of microtubules.
305
This is true even in the case of microtubules assembled from pure tubulin in-vitro. In 306 these experiments, a decrease in tubulin heterodimer concentration leads to an 307 increase in the frequency of catastrophe events [53] and to a decrease in the rate of 
325
To determine how a relatively sudden 15-20% dilution of the tubulin pool is likely to 326 affect microtubule polymer levels in mitosis, we established an assay enabling us to 327 induce a similar, rapid reduction in the in vivo concentration of tubulin heterodimers 328 using hypo-osmotic shock ( Figure S3 A). While the control treatment did not trigger 329 any significant changes in either mEGFP-a-tubulin intensity or in the cell dimeter, 330 hypo-osmotic shock induced changes in tubulin heterodimer concentration that were 331 quantitatively similar to those observed at NEP: a 6.3±2.5% increase in the cell 332 diameter and a concomitant 16.2±2.8% decrease in the mEGFP-a-tubulin signal 333 within two minutes of the shock ( Figure S3 A-C). To test whether this is sufficient to 334 reduce microtubule polymer levels, as expected under this model, we repeated this 335 analysis in cells that had been arrested in mitosis using MG132 treatment. Under 336 these conditions, a dilution of tubulin dimers equivalent to that observed at NEP 337 triggered a dramatic reduction in the levels of tubulin polymer. Within two minutes of 338 the shock, we observed a 11.4±3.7% decrease in the mEGFP-a-tubulin signal within 339 the mitotic spindle and an accompanying 20±10% decrease in the mitotic spindle 340 volume ( Figure 5 A-C).
342
For the converse experiment we established a protocol to increase the tubulin dimer 343 concentration using hyper-osmotic shock ( Figure 
357
In this study, we explore how interphase microtubule disassembly is influenced by 
377
The mechanism contributing to interphase microtubule disassembly 378 Our analysis points to there being two distinct processes at play. First, the rise of 379 Cdk1/CyclinB activity that drives entry into mitosis induces the phosphorylation of a 380 microtubule stabilizing protein, Ensconsin. This reduces its affinity for microtubules 381 [39, 43] , making interphase microtubules susceptible to subsequent disassembly.
382
Although these data suggest a specific role for Cdk1/CyclinB in this regulation, the 383 experiments performed do not exclude a role for other mitotic kinases (including 384 Nek2). In addition, even though our data point to the importance of the timely 385 removal of Ensconsin from interphase microtubules, it is likely that the 386 phosphorylation of other MAPs by mitotic kinases also contributes to this process.
387
Indeed, previous work has suggested that the phosphorylation MAP4 by Cdk1 388 14 reduces its ability to stabilize microtubules [59, 60] . Moreover, Plk1, another major 389 mitotic kinase, has been shown to stimulate microtubule polymerization activity of 390 MCAK, a key regulator of microtubule dynamics [61, 62] . Thus, the activation of 391 CDK1/CyclinB is likely to trigger the remodelling of the microtubule cytoskeleton 392 through several parallel processes. While this is the case, our data show that while 393 the rise in mitotic kinase activity sets the stage for the depolymerisation of 394 microtubules following the loss of nuclear/cytoplasmic compartment boundary, it is 395 not in itself sufficient for the complete disassembly of interphase microtubules. 
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Depletion of Ensconsin was verified by Immunoblotting. siRNA treated cells were 504 lysed with 1XSB (Invitrogen) were loaded onto an SDS-PAGE gel before transfer 505 onto an Immobilon-P (Millipore) membrane by wet western blotting. Membranes were 506 blocked in 5% BSA in TBST for 1 hr, incubated overnight at 4C with primary 507 antibodies, and for an hour at room temperature with secondary antibodies.
508
Antibodies were used at the following dilutions: Ensconsin (MAP7) 1:2500 509 (Proteintech, 13446-1-AP) and a-tubulin 1:5000 (DM1A, Sigma) and HRP-510 conjugated secondary antibodies 1:5000 (DAKO). Results were visualized using an 511 ImageQuant LAS4000 system.
512
Drugs were used at the following concentrations: 100 ng/ml nocodozole (Sigma), 1 or (Figure S1 A) . The values displayed in the graphs are background subtracted 573 and normalized by the values at NEP or at -30 min before NEP, as indicated. In 574 addition, cytoplasmic mEGFP-a-tubulin intensity (value at 6 min after the NEP) was 575 subtracted before normalization (Except in the graphs in Figure S1 ). In the figure 1 D 
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Step 2 hite arrows indicate to microtubule clumps formed due to a failure to remove Ensconsin from microtubules before NEP. Black arrows indicate to interphase microtubules just before or after NEP (1 cells t-EMTB-mcherry, 15 cells A-EMTB-mcherry, 5 independentexperiments). In overlay images, signal intensities were adjusted to remove cytoplasmic background signal. Scale bars represent 10μm. A) Changes in non-centrosomal microtubule levels relative to NEP. Variance of α-tubulin-GFP signal measured as described in Figure S1 D for control siRNA (blue, 5 cells) and Cep192 siRNA cells (brown, 5 cells) 2 experiments as in Figure 2 A-C. B) Western blot showing Ensconsin knockdown induced using three different siRNAs targeting Ensconsin. C) Representative confocal images (x-y maximum projection) of fixed HeLa cells treated with control siRNA and three siRNAs targeting Ensconsin. Inserts show regions zoomed in overlays (>10 cells per condition, 1 experiment). D) Representative confocal images (x-y maximum projection) of fixed MCF10A cells stained to show that Ensconsin is removed from microtubules in prophase compared to interphase. Ensconsin in red, αTubulin in green and DAPI in blue. Inserts show regions zoomed in overlays, in which intensities were adjusted to remove cytoplasmic background signal (6 prophase cells, >20 interphase cells,1 experiment). E) Representative confocal images of fixed HeLa cells overexpressing Rap1* in prophase stained to show that the microtubule binding domain of Ensconsin (Wt-EMTB-mCherry) as well as a corresponding phospho-mimetic mutant (E-EMTB-mCherry) are largely cytoplasmic in prophase, whereas the non-phosphorylatable form (A-EMTB-mCherry) localizes to the microtubules. αTubulin in green, Wt-EMTB-mCherry, A-EMTB-mCherry, E-EMTB-mCherry in red. Inserts are zoomed, shown in inverted greyscale or in overlays, where signal intensities were adjusted to remove cytoplasmic background signal (3 cells per condition, 1 experiment). Scale bars represent 10μm. A) Representative time-lapse confocal images (x-y maximum projection, lower panel: pseudocolor, spectra LUT) of HeLa cells stably expressing H2B-mRFP (was not imaged) and mEGFP-α-tubulin, treated with Nocodazole, to show changes in cell diameter and in mEGFP-α-tubulin intensity before and after hypo-or hyper-osmotic shock treatment relative to control treatment. Scale bar represents 10μm. B) Quantifications of changes in mEGFP-α-tubulin intensity induced by osmotic shock relative to control treatment. Mean intensity of mEGFP-α-tubulin signal was measured in cells before and after control (blue, cells), hypo-(red, cells) or hyper-(green, cells) osmotic shock treatments (2 independent experiments) as described in Materials and Methods. C) uantifications of changes in cell diameter (Ferret s diameter) induced by osmotic shock relative to control treatment. Ferret's diameter was measured as described in Materials and Methods in cells before and after control (blue, cells), hypo-(red, cells) or hyper-(green, cells) osmotic shock treatments (2 independent experiments). Lower panels show comparison between values at -0.5 min and 2 min relative to osmotic shock treatments. Repeated Measures two-way ANOVA, Dunnett's multiple comparisons test, **** P=0.0001
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